Jane Street’s DICE Therapeutics DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-7,300
Closed -$339K – 9885
2023
Q2
$339K Buy
+7,300
New +$252K ﹤0.01% 7069
2022
Q4
– Sell
-15,300
Closed -$310K – 10675
2022
Q3
$310K Buy
+15,300
New +$279K ﹤0.01% 7720

Jane Street's DICE Position: Q3 2023 in Review

Jane Street sold out of DICE Therapeutics (DICE) in Q3 2023, closing a stake of 22,740 shares — an estimated $1.06M sold.

Jane Street first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $1.06M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Jane Street reported no remaining DICE Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Jane Street sold 22,740 DICE Therapeutics shares in Q3 2023, an estimated $1.06M.
  • Jane Street first reported a position in DICE Therapeutics in Q4 2022 and held it in 3 quarters.
  • Jane Street's DICE Therapeutics position peaked at $1.06M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.